Download video

Dispatch Exposes W Korea’s Breast Cancer Charity Campaign, Alcohol, Brands, and Fake Charity Claims!

12 views

Story Gossipe

5 hours ago

Dispatch Exposes W Korea’s Breast Cancer Charity Campaign, Alcohol, Brands, and Fake Charity Claims!

Dispatch Exposes W Korea’s Breast Cancer Charity Campaign, Alcohol, Brands, and Fake Charity Claims!

The OncoAlert TOP5 of Day 2 of #esmo25 :DESTINY Breast 11, DESTINY Breast 05, KN905, evERA \& RAMPART
3:36
The OncoAlert TOP5 of Day 2 of #esmo25 :DESTINY Breast 11, DESTINY Breast 05, KN905, evERA \& RAMPART
by OncoAlert 360
The OncoAlert Weekly Round Up Sept 25-Oct 2, 2025 : DESTINY Breast05 \/ NATALEE \/ PROGRESS
4:09
The OncoAlert Weekly Round Up Sept 25-Oct 2, 2025 : DESTINY Breast05 \/ NATALEE \/ PROGRESS
by OncoAlert 360
HER2CLIMB-05: Tucatinib Boosts PFS in HER2+ Metastatic Breast Cancer
0:31
HER2CLIMB-05: Tucatinib Boosts PFS in HER2+ Metastatic Breast Cancer
by OncoAlert 360
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
0:48
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
by VJOncology
Upcoming trials assessing ADCs in HER2+ breast cancer in 2024
1:11
Upcoming trials assessing ADCs in HER2+ breast cancer in 2024
by VJOncology
AstraZeneca’s Enhertu Cuts Breast Cancer Risk by 53% in Major Clinical Trials
2:49
AstraZeneca’s Enhertu Cuts Breast Cancer Risk by 53% in Major Clinical Trials
by India Today Global
HER2 Breast Cancer Treatment - DM(AIIMS) - Stage 4 to Stage 1 with Targeted Therapy in Hindi 2024
9:34
HER2 Breast Cancer Treatment - DM(AIIMS) - Stage 4 to Stage 1 with Targeted Therapy in Hindi 2024
by Dr Vineet Govinda Gupta
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
5:30
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
by OncologyTube
Breast Cancer Motion Graphic
1:03
Breast Cancer Motion Graphic
by Jefferson Health New Jersey
MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape
1:00:45
MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research \& Treatment Landscape
by Susan G. Komen®
Evaluating predictors of benefit of CDK4\/6 inhibition in breast cancer
0:35
Evaluating predictors of benefit of CDK4\/6 inhibition in breast cancer
by VJOncology
Cancer Found with SecondReadAI
0:48
Cancer Found with SecondReadAI
by Rezolut
I-SPY 2: advancing outcomes high-risk breast cancer through adapting therapies
1:46
I-SPY 2: advancing outcomes high-risk breast cancer through adapting therapies
by VJOncology
Managing Toxicities of CDK4\/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
22:22
Managing Toxicities of CDK4\/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
by OncBrothers: Practice-Changing Cancer Discussions
Tucatinib Targeted Therapy and Doxil Chemotherapy for Advanced HER2+ Breast Cancer
4:13
Tucatinib Targeted Therapy and Doxil Chemotherapy for Advanced HER2+ Breast Cancer
by MBC Brain Mets
Breast Cancer Awareness Month: Importance of screening, latest in treatment
6:53
Breast Cancer Awareness Month: Importance of screening, latest in treatment
by CBS Boston
ASCO25: Skip Carboplatin in HER2+ Breast Cancer?
4:02
ASCO25: Skip Carboplatin in HER2+ Breast Cancer?
by Cancer Treatment Updates
Will stopping the drug make my breast cancer come back?
9:34
Will stopping the drug make my breast cancer come back?
by Dr Liz O'Riordan
#CheckYourselfToo | Breast Cancer Awareness 2025
1:29
#CheckYourselfToo | Breast Cancer Awareness 2025
by Fortis Healthcare
VERITAC-2: vepdegestrant versus fulvestrant in ER+\/HER2- breast cancer
1:35
VERITAC-2: vepdegestrant versus fulvestrant in ER+\/HER2- breast cancer
by VJOncology
Scanning for breast cancer can also detect heart disease, doctors say
2:05
Scanning for breast cancer can also detect heart disease, doctors say
by CBS Boston
Fake Cancer. (Part 2)
59:26
Fake Cancer. (Part 2)
by Crime Bytes
A Breast Surgeon Breaks Down Your Biopsy Report
33:01
A Breast Surgeon Breaks Down Your Biopsy Report
by Dr Alex Popadich